Radioiodinated Small-Molecule Tyrosine Kinase Inhibitor for HER2-Selective SPECT Imaging

Conclusion: The radiolabeled HER2-selective inhibitor 125/131I-IBA-CP is a promising probe for in vivo detection of HER2-positive tumors.

Source: Journal of Nuclear Medicine - September 4, 2018 Category: Nuclear Medicine Authors: Tang, L., Peng, C., Tang, B., Li, Z., Wang, X., Li, J., Gao, F., Huang, L., Xu, D., Zhang, P., Zhuang, R., Su, X., Chen, X., Zhang, X. Tags: Basic Source Type: research